1 | EPHA3 |
Copy number variations of EphA3 are associated with multiple types of hematologic malignancies. | |
Guan M, Liu L, Zhao X, Wu Q, Yu B, Shao Y, Yang H, Fu X, Wan J, Zhang W. | |
Clin Lymphoma Myeloma Leuk 11(1):50-3. 2011 | |
2 | EPHA3, PROM1 |
Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma. | |
Xi HQ, Zhao P. | |
J Clin Pathol 64(6):498-503. Epub 2011 Mar 17. 2011 | |
3 | EPHA3, PTPN1 |
PTP1B regulates Eph receptor function and trafficking. | |
Nievergall E, Janes PW, Stegmayer C, Vail ME, Haj FG, Teng SW, Neel BG, Bastiaens PI, Lackmann M. | |
J Cell Biol 191(6):1189-203. Epub 2010 Dec 6. 2010 | |
4 | EPHA3 |
Structural recognition of an optimized substrate for the ephrin family of receptor tyrosine kinases. | |
Davis TL, Walker JR, Allali-Hassani A, Parker SA, Turk BE, Dhe-Paganon S. | |
FEBS J 276(16):4395-404. 2009 | |
5 | EPHA2, EPHA3 |
Ephrins as negative regulators of adult neurogenesis in diverse regions of the central nervous system. | |
Jiao JW, Feldheim DA, Chen DF. | |
Proc Natl Acad Sci U S A 105(25):8778-83. Epub 2008 Jun 18. 2008 | |
6 | APC, ATM, EPHA3, ERBB2, ERBB4, FGFR4 |
Somatic mutations affect key pathways in lung adenocarcinoma. | |
Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, Fulton L, Fulton RS, Zhang Q, Wendl MC, Lawrence MS, Larson DE, Chen K, Dooling DJ, Sabo A, Hawes AC, Shen H, Jhangiani SN, Lewis LR, Hall O, Zhu Y, Mathew T, Ren Y, Yao J, Scherer SE, Clerc K, Metcalf GA, Ng B, Milosavljevic A, Gonzalez-Garay ML, Osborne JR, Meyer R, Shi X, Tang Y, Koboldt DC, Lin L, Abbott R, Miner TL, Pohl C, Fewell G, Haipek C, Schmidt H, Dunford-Shore BH, Kraja A, Crosby SD, Sawyer CS, Vickery T, Sander S, Robinson J, Winckler W, Baldwin J, Chirieac LR, Dutt A, Fennell T, Hanna M, Johnson BE, Onofrio RC, Thomas RK, Tonon G, Weir BA, Zhao X, Ziaugra L, Zody MC, Giordano T, Orringer MB, Roth JA, Spitz MR, Wistuba II, Ozenberger B, Good PJ, Chang AC, Beer DG, Watson MA, Ladanyi M, Broderick S, Yoshizawa A, Travis WD, Pao W, Province MA, Weinstock GM, Varmus HE, Gabriel SB, Lander ES, Gibbs RA, Meyerson M, Wilson RK. | |
Nature 455(7216):1069-75. 2008 | |
7 | EPHA3 |
The EphA3 receptor is expressed in a subset of rhabdomyosarcoma cell lines and suppresses cell adhesion and migration. | |
Clifford N, Smith LM, Powell J, Gattenlöhner S, Marx A, O'Connor R. | |
J Cell Biochem 105(5):1250-9. 2008 | |
8 | MAP3K2, ZAK, FER, EPHA3 |
Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry. | |
Wissing J, JŠnsch L, Nimtz M, Dieterich G, Hornberger R, KŽri G, Wehland J, Daub H. | |
Mol Cell Proteomics 6(3):537-47. Epub 2006 Dec 27. 2007 | |
9 | EPHA3, NTRK3, GUCY2F |
Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers. | |
Wood LD, Calhoun ES, Silliman N, Ptak J, Szabo S, Powell SM, Riggins GJ, Wang TL, Yan H, Gazdar A, Kern SE, Pennacchio L, Kinzler KW, Vogelstein B, Velculescu VE. | |
Hum Mutat 27(10):1060-1. 2006 | |
10 | EPHA3 |
EphA3 is induced by CD28 and IGF-1 and regulates cell adhesion. | |
Smith LM, Walsh PT, RŸdiger T, Cotter TG, Mc Carthy TV, Marx A, O'Connor R. | |
Exp Cell Res 292(2):295-303. 2004 | |
11 | EFNA2, EPHA3 |
Multiple roles of EPH receptors and ephrins in neural development. | |
Wilkinson DG. | |
Nat Rev Neurosci 2(3):155-64. Review. 2001 | |
12 | EPHA3 |
Cloning and characterization of EphA3 (Hek) gene promoter: DNA methylation regulates expression in hematopoietic tumor cells. | |
Dottori M, Down M, Huttmann A, Fitzpatrick DR, Boyd AW. | |
Blood 94(7):2477-86. 1999 | |
13 | EPHA3 |
Localization of a human receptor tyrosine kinase (ETK1) to chromosome region 3p11.2. | |
Wicks IP, et al. | |
Genomics 19 : 38-41. 1994 | |
14 | EPHA3 |
Molecular cloning of HEK, the gene encoding a receptor tyrosine kinase expressed by human lymphoid tumor cell lines. | |
Wicks IP, et al. | |
Proc Natl Acad Sci U S A 89 : 1611-1615. 1992 | |